Ritter Pharmaceuticals

$0.3274
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.756 (-70.00%) Today
+$0.0034 (1.05%) As of 7:34 PM EDT after-hours

Why Robinhood?

You can buy or sell RTTR and other stocks, options, ETFs, and crypto commission-free!

About RTTR

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. Read More The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.

Employees
7
Headquarters
Los Angeles, California
Founded
2004
Market Cap
3.05M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.34M
High Today
$0.3387
Low Today
$0.2901
Open Price
$0.30
Volume
7.29M
52 Week High
$2.56
52 Week Low
$0.2901

Collections

RTTR Earnings

-$1.66
-$1.12
-$0.59
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.